Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Clinician's Roundtable

Developments in DMD Treatment: The First Nonsteroidal Drug Approval

ReachMD Healthcare Image
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Comments
  • Overview

    Explore the data that led to the FDA approval of givinostat, the first nonsteroidal treatment option for patients with duchenne muscular dystrophy, with this brief recap.

Recommended
Details
Comments
  • Overview

    Explore the data that led to the FDA approval of givinostat, the first nonsteroidal treatment option for patients with duchenne muscular dystrophy, with this brief recap.

Schedule4 Oct 2024